1
|
Nakata E, Fujiwara T, Kunisada T, Ito T,
Takihira S and Ozaki T: Immunotherapy for sarcomas. Jpn J Clin
Oncol. 51:523–537. 2021.PubMed/NCBI View Article : Google Scholar
|
2
|
Mineda A, Nishimura M, Kagawa T, Takiguchi
E, Kawakita T, Abe A and Irahara M: Resveratrol suppresses
proliferation and induces apotosis of uterine sarcoma cells by
inhibiting the Wnt signaling pathway. Exp Ther Med. 17:2242–2246.
2019.PubMed/NCBI View Article : Google Scholar
|
3
|
Zou Y, Yang J and Jiang D: Resveratrol
inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells.
Mol Med Rep. 12:7221–7226. 2015.PubMed/NCBI View Article : Google Scholar
|
4
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, et al: Cancer chemopreventive activity of resveratrol, a
natural product derived from grapes. Science. 275:218–220.
1997.PubMed/NCBI View Article : Google Scholar
|
5
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004.PubMed/NCBI View Article : Google Scholar
|
6
|
Lavergne E, Hendaoui I, Coulouarn C,
Ribault C, Leseur J, Eliat PA, Mebarki S, Corlu A, Clément B and
Musso O: Blocking Wnt signaling by SFRP-like molecules inhibits in
vivo cell proliferation and tumor growth in cells carrying active
β-catenin. Oncogene. 30:423–433. 2011.PubMed/NCBI View Article : Google Scholar
|
7
|
Wu Q, Xu C, Zeng X, Zhang Z, Yang B and
Rao Z: Tumor suppressor role of sFRP-4 in hepatocellular carcinoma
via the Wnt/β-catenin signaling pathway. Mol Med Rep.
23(336)2021.PubMed/NCBI View Article : Google Scholar
|
8
|
De La Cruz MS and Buchanan EM: Uterine
fibroids: Diagnosis and treatment. Am Fam Physician. 95:100–107.
2017.PubMed/NCBI
|
9
|
Pridgeon MG, Grohar PJ, Steensma MR and
Williams BO: Wnt signaling in ewing sarcoma, osteosarcoma, and
malignant peripheral nerve sheath tumors. Curr Osteoporos Rep.
15:239–246. 2017.PubMed/NCBI View Article : Google Scholar
|
10
|
Singla A, Wang J, Yang R, Geller DS, Loeb
DM and Hoang BH: Wnt signaling in osteosarcoma. Adv Exp Med Biol.
1258:125–139. 2020.PubMed/NCBI View Article : Google Scholar
|
11
|
Ford CE, Jary E, Ma SSQ, Nixdorf S,
Heinzelmann-Schwarz VA and Ward RL: The Wnt gatekeeper SFRP4
modulates EMT, cell migration and downstream Wnt signalling in
serous ovarian cancer cells. PLoS One. 8(e54362)2013.PubMed/NCBI View Article : Google Scholar
|
12
|
Ridley AJ, Schwartz MA, Burridge K, Firtel
RA, Ginsberg MH, Borisy G, Parsons JT and Horwitz AR: Cell
migration: Integrating signals from front to back. Science.
302:1704–1709. 2003.PubMed/NCBI View Article : Google Scholar
|
13
|
Kikuchi A, Yamamoto H and Kishida S:
Multiple of the interactions of Wnt proteins and their receptors.
Cell Signal. 19:659–671. 2007.PubMed/NCBI View Article : Google Scholar
|
14
|
Fang F, VanCleave A, Helmuth R, Torres H,
Rickel K, Wollenzien H, Sun H, Zeng E, Zhao J and Tao J: Targeting
the Wnt/β-catenin pathway in human osteosarcoma cells. Oncotarget.
9:36780–36792. 2018.PubMed/NCBI View Article : Google Scholar
|
15
|
Rattner A, Hsieh JC, Smallwood PM, Gilbert
DJ, Copeland NG, Jenkins NA and Nathans J: A family of secreted
proteins contains homology to the cysteine-rich ligand-binding
domain of frizzled receptors. Proc Natl Acad Sci USA. 94:2859–2863.
1997.PubMed/NCBI View Article : Google Scholar
|
16
|
Suzuki H, Watkins DN, Jair KW, Schuebel
KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van
Engeland M, et al: Epigenetic inactivation of SFRP genes allows
constitutive WNT signaling in colorectal cancer. Nat Genet.
36:417–422. 2004.PubMed/NCBI View
Article : Google Scholar
|
17
|
Ko J, Ryu KS, Lee YH, Na DS, Kim YS, Oh
YM, Kim IS and Kim JW: Human secreted frizzled-related protein is
down-regulated and induces apoptosis in human cervical cancer. Exp
Cell Res. 280:280–287. 2002.PubMed/NCBI View Article : Google Scholar
|
18
|
Chung MT, Lai HC, Sytwu HK, Yan MD, Shih
YL, Chang CC, Yu MH, Liu HS, Chu DW and Lin YW: SFRP1 and SFRP2
suppress the transformation and invasion abilities of cervical
cancer cells through Wnt signal pathway. Gynecol Oncol.
112:646–653. 2009.PubMed/NCBI View Article : Google Scholar
|
19
|
Lin YW, Chung MT, Lai HC, Yan MD, Shih YL,
Chang CC and Yu MH: Methylation analysis of SFRP genes family in
cervical adenocarcinoma. J Cancer Res Clin Oncol. 135:1665–1674.
2009.PubMed/NCBI View Article : Google Scholar
|
20
|
Jacob F, Ukegjini K, Nixdorf S, Ford CE,
Olivier J, Caduff R, Scurry JP, Guertler R, Hornung D, Mueller R,
et al: Loss of secreted frizzled-related protein 4 correlates with
an aggressive phenotype and predicts poor outcome in ovarian cancer
patients. PLoS One. 7(e31885)2012.PubMed/NCBI View Article : Google Scholar
|
21
|
Kawauchi T: Cell adhesion and its
endocytic regulation in cell migration during neural development
and cancer metastasis. Int J Mol Sci. 13:4564–4590. 2012.PubMed/NCBI View Article : Google Scholar
|
22
|
Mei J, Jin LP, Ding D, Li MQ, Li DJ and
Zhu XY: Inhibition of IDO1 suppresses cyclooxygenase-2 and matrix
metalloproteinase-9 expression and decreases proliferation,
adhesion and invasion of endometrial stromal cells. Mol Hum Reprod.
18:467–476. 2012.PubMed/NCBI View Article : Google Scholar
|
23
|
Tsukamoto H, Kondo S, Mukudai Y, Nagumo T,
Yasuda A, Kurihara Y, Kamatani T and Shintani S: Evaluation of
anticancer activities of benzo[c]phenanthridine alkaloid
sanguinarine in oral squamous cell carcinoma cell line. Anticancer
Res. 31:2841–2846. 2011.PubMed/NCBI
|